Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 521.50
Bid: 522.50
Ask: 524.00
Change: 4.00 (0.77%)
Spread: 1.50 (0.287%)
Open: 516.50
High: 526.50
Low: 509.00
Prev. Close: 517.50
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal programme successfully concluded

1 Mar 2023 07:00

RNS Number : 4744R
Babcock International Group PLC
01 March 2023
 

01 March 2023

 

Disposal programme successfully concluded

 

Babcock International Group PLC ("Babcock" or "the Group") is pleased to announce the conclusion of its portfolio alignment programme with the completion of the sale of certain of its aerial emergency businesses (AES) to Ancala Partners.

As announced on 19 July 2022, the AES businesses were sold for a cash consideration of €136.2 million (c. £120 million), before completion adjustments and transaction costs. The proceeds will be used to reduce debt.

This follows the sale of part of Babcock's civil training business to Inspirit Capital on 01 February 2023.

The completion of these two disposals concludes the Group's programme of portfolio alignment designed to reduce complexity, focus the Group on its chosen markets and strengthen the balance sheet.

The programme, initially announced on 13 April 2021, has generated gross proceeds of c. £570 million and transferred leases of c. £340 million. As a result, defence now accounts for around two-thirds of Group revenue.

Babcock CEO David Lockwood said:

"We've done what we said we'd do at the start of our turnaround: we've strengthened the balance sheet and reduced complexity. Around two-thirds of the Group is now focused on defence, and we are well positioned for future growth opportunities in our core markets.

"The AES and civil training businesses are both in good hands, and I wish their new owners every success in growing the businesses further."

 

ENDS

 

 

For further information:

 

Andrew Gollan, Director of Investor Relations

+44 (0)7936 039004

Kate Hill, Group Director of Communications

+44 (0)20 7355 5312

 

Tulchan Communications

 

Olivia Peters / Harry Cameron

+44 (0)20 7353 4200  

 

 

Note: The AES businesses sold provide aerial emergency medical services, firefighting and search & rescue to customers and communities in Italy, Spain, Portugal, Norway, Sweden and Finland and had revenue of £405 million in FY22 and a profit contribution of £13 million. Babcock retains its aerial emergency services businesses in its focus countries of the UK, France, Canada and Australia.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJBMFTMTBMMFJ
Date   Source Headline
13th Oct 20161:14 pmRNSContract Award
4th Oct 201612:46 pmRNSPublication of Final Terms
23rd Sep 20164:45 pmRNSHolding(s) in Company
20th Sep 201611:37 amRNSPublication of a Prospectus
16th Sep 201612:39 pmRNSHolding(s) in Company
8th Sep 20169:00 amRNSContract Award
16th Aug 20164:44 pmRNSDirector/PDMR Shareholding
29th Jul 20164:30 pmRNSDirector/PDMR Shareholding
21st Jul 20164:32 pmRNSResult of AGM
21st Jul 20167:00 amRNSAnnual General Meeting Trading Update
20th Jul 20163:45 pmRNSHolding(s) in Company
8th Jul 20169:31 amRNSHolding(s) in Company
28th Jun 20169:13 amRNSDirector/PDMR Shareholding
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
20th Jun 20163:17 pmRNSDirector/PDMR Shareholding
17th Jun 201610:22 amRNSDirector/PDMR Shareholding
16th Jun 20163:44 pmRNSDirector/PDMR Shareholding
16th Jun 20169:14 amRNSAnnual Report and AGM Documents
14th Jun 20163:50 pmRNSDirector/PDMR Shareholding
3rd Jun 20161:56 pmRNSTotal Voting Rights
31st May 20163:29 pmRNSAdditional Listing
25th May 20167:00 amRNSFinal Results
20th May 20168:00 amRNSContract Announcement
18th May 20164:10 pmRNSHolding(s) in Company
12th May 20162:05 pmRNSDirector/PDMR Shareholding
12th May 20162:04 pmRNSDirector/PDMR Shareholding
13th Apr 20164:32 pmRNSDirector/PDMR Shareholding
13th Apr 20164:29 pmRNSDirector/PDMR Shareholding
14th Mar 20162:14 pmRNSDirector/PDMR Shareholding
14th Mar 201610:37 amRNSHolding(s) in Company
29th Feb 201610:02 amRNSHolding(s) in Company
17th Feb 201610:00 amRNSPhoenix II contract award
16th Feb 201610:24 amRNSAdoption of Financial Reporting Standard (FRS) 101
12th Feb 20163:24 pmRNSDirector/PDMR Shareholding
8th Feb 20164:20 pmRNSDirector/PDMR Shareholding
5th Feb 201611:01 amRNSDirector/PDMR Shareholding
3rd Feb 20161:33 pmRNSDirector/PDMR Shareholding
2nd Feb 201611:05 amRNSAscent joint venture contract award
28th Jan 20167:00 amRNSCEO succession
18th Jan 20163:15 pmRNSDirector/PDMR Shareholding
15th Jan 20164:54 pmRNSDirector/PDMR Shareholding
14th Dec 201511:32 amRNSDirector/PDMR Shareholding
11th Dec 201510:02 amRNSS430 (2B) Companies Act 2006
10th Dec 201510:46 amRNSDirectorate Change
1st Dec 20151:38 pmRNSDirector/PDMR Shareholding
26th Nov 201510:14 amRNSHolding(s) in Company
24th Nov 20153:00 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSHalf Yearly Report
6th Nov 20154:00 pmRNSHolding(s) in Company
23rd Oct 201511:17 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.